Clinical Design
Clinical Design is a lens for healthcare implementation. It describes how healthcare innovation and the care delivery environment around it must be designed together if adoption, evidence generation and scale are to be possible.
​
Rather than treating implementation as a downstream logistics problem, Clinical Design treats it as a design problem from the outset: one that includes pathways, workflows, governance, evidence, incentives and operational reality.
​
Clinical Design is a public framework developed by Marcos Gallego Llorente through teaching, writing and public research. It is intended for general analysis and implementation, rather than as a stakeholder-specific methodology.
Why Clinical Design
Healthcare has become exceptionally good at discovery and unusually weak at integration.
​
We now produce more powerful therapies, algorithms, diagnostics and care innovations than ever before. However, many of them still fail at the same point: not in the lab, not in the trial, and not even at approval, but in the real environment of care delivery.
​
- A therapy may be effective but hard to initiate.
- A digital tool may be accurate but absent from workflow.
- A pathway may be evidence-based but operationally impossible.
- A care model may succeed in pilot form and fail at scale.
​
This is not a secondary problem; this is increasingly the central problem.
​
Clinical design begins from a simple premise: implementation is not a logistics afterthought. It is a design discipline in its own right.
The Canonical Definition
Clinical design is the simultaneous design of healthcare innovation and the care delivery environment.
Clinical design is about making innovation work. That means designing the innovation and the ecosystem together: the clinical workflow, the referral logic, the ownership model, the data environment, the evidence loop and the economic structure through which adoption will either happen or break.
​
It asks a different question from traditional innovation strategy. Under what real-world conditions will it be used, trusted, maintained, paid for and scaled? That is the central problem clinical design exists to solve.
What Clinical Design is Not
Clinical Design is not clinical trial design, user-interface polish, digital branding, or implementation treated as an afterthought. It is not a narrow function within market access, medical affairs, health policy or product strategy, even though it overlaps with all of them. Clinical Design is the integrative layer that asks whether a therapy, technology or model of care can survive contact with real-world delivery and reach routine use at scale.
The Vowels of Clinical Design — AEIOU
A clinically designed innovation should be adopted, proven, connected, owned and sustainable. These five dimensions form the central framework.
​
In that sense, it is both strategic and operational, both scientific and systemic.
A
Adoption
Adoption is where many innovations quietly fail. Not because clinicians resist change in the abstract, but because care delivery is already cognitively overloaded, operationally constrained and time-poor. If an innovation adds clicks, screens, workarounds, uncertainty or fragmentation, adoption will stall. Clinical design asks: does this fit naturally inside the clinical moment, or does it demand that clinicians step outside reality to use it? The goal is not visible complexity. The goal is near-invisible usefulness.
The HUMAN Layer
E
The VALIDATION Layer
Evidence
Regulatory approval is permission to enter the market. It is not proof of durable value in practice. Clinical design treats evidence not as a one-time event, but as a live system: outcomes, drift, safety, performance, variation and real-world utility must continue to be measured after launch. Evidence, in this framework, is a loop.
I
Interoperability
Most healthcare innovations do not enter a clean environment. They enter fragmented infrastructures, incompatible systems, heterogeneous workflows and context-poor data. True interoperability means that information can move with meaning, at the right time, to the right place, in a form that supports decision-making rather than adding another silo. Clinical design asks: does the innovation reduce fragmentation, or does it create a new fragmentation tax?
The SYSTEM Layer
O
Ownership
Many healthcare pilots fail for a simple reason: nobody truly owns them. Ownership in clinical design means clear accountability for implementation, maintenance, escalation, governance, risk and iteration. Without ownership, innovation becomes orphaned. With ownership, it becomes governable. The question is simple: who is accountable for making this work in reality?
The GOVERNANCE Layer
U
The FINANCIAL Layer
Unit Economics
Misaligned incentives kill more innovations than poor intentions. If one stakeholder pays while another captures the value, adoption becomes unstable. Clinical design treats economics as part of the product itself. The path from pilot to scale requires budget clarity, procurement realism and a credible logic for sustained value creation. The key question is: who pays, who benefits, and are those incentives aligned strongly enough to keep the innovation alive?
If you miss one vowel of clinical design, you may still have science. You may still have code. You may still have a pilot.
But you do not yet have scalable reality.
The Laws of Clinical Design
Every serious discipline has laws. Clinical design is no exception.
Law 1
Friction beats accuracy
A highly accurate tool that adds operational friction will often lose to a less elegant one that saves time and reduces burden. In healthcare, time is frequently scarcer than intelligence.
Law 2
The clinical moment is sacred
If an innovation is absent from the actual decision window — the bedside, the workflow, the viewer, the prescribing moment, the MDT, the live handoff — it is functionally absent. Clinicians should not have to leave reality to use a product.
Law 3
Incentives are part of the product
A therapy, tool or model is not fully designed unless its economic and organisational logic is also designed. Payment logic, accountability and stakeholder incentives are not externalities. They are part of implementation physics.
Law 4
Evidence is a loop, not an event
The old model assumes that study, approval and launch complete the proof. Clinical design assumes the opposite: launch begins a new cycle of monitoring, refinement, adaptation and validation.
Why it Matters Now
The case for clinical design is becoming stronger:
- Biomedical discovery is accelerating.
- Digital capability is accelerating.
- AI-enabled analysis is accelerating.
But care delivery infrastructure often remains fragmented, underpowered and slow to adapt.
​
The consequence is predictable: innovation advances faster than implementation capacity. That gap is where value is lost, pilots stall, inequities widen and promising ideas fail to scale.
​
Clinical design exists to close that gap. It is the blueprint discipline for an era in which invention alone is no longer enough.